JP2005511491A5 - - Google Patents

Download PDF

Info

Publication number
JP2005511491A5
JP2005511491A5 JP2003511855A JP2003511855A JP2005511491A5 JP 2005511491 A5 JP2005511491 A5 JP 2005511491A5 JP 2003511855 A JP2003511855 A JP 2003511855A JP 2003511855 A JP2003511855 A JP 2003511855A JP 2005511491 A5 JP2005511491 A5 JP 2005511491A5
Authority
JP
Japan
Prior art keywords
peptide
concentration
composition
kit according
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003511855A
Other languages
English (en)
Japanese (ja)
Other versions
JP4845166B2 (ja
JP2005511491A (ja
Filing date
Publication date
Priority claimed from GBGB0117057.0A external-priority patent/GB0117057D0/en
Application filed filed Critical
Publication of JP2005511491A publication Critical patent/JP2005511491A/ja
Publication of JP2005511491A5 publication Critical patent/JP2005511491A5/ja
Application granted granted Critical
Publication of JP4845166B2 publication Critical patent/JP4845166B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003511855A 2001-07-12 2002-07-08 ゲルを形成する濃度の性腺刺激ホルモン放出ホルモン拮抗物質 Expired - Lifetime JP4845166B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0117057.0A GB0117057D0 (en) 2001-07-12 2001-07-12 Pharmaceutical composition
GB0117057.0 2001-07-12
PCT/GB2002/003116 WO2003006049A1 (en) 2001-07-12 2002-07-08 Gonadotropin releasing hormone antagonists in gel-forming concentrations

Publications (3)

Publication Number Publication Date
JP2005511491A JP2005511491A (ja) 2005-04-28
JP2005511491A5 true JP2005511491A5 (cg-RX-API-DMAC7.html) 2007-05-24
JP4845166B2 JP4845166B2 (ja) 2011-12-28

Family

ID=9918396

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003511855A Expired - Lifetime JP4845166B2 (ja) 2001-07-12 2002-07-08 ゲルを形成する濃度の性腺刺激ホルモン放出ホルモン拮抗物質

Country Status (13)

Country Link
US (4) US20040038903A1 (cg-RX-API-DMAC7.html)
EP (1) EP1404357B1 (cg-RX-API-DMAC7.html)
JP (1) JP4845166B2 (cg-RX-API-DMAC7.html)
AR (1) AR036337A1 (cg-RX-API-DMAC7.html)
AT (1) ATE452648T1 (cg-RX-API-DMAC7.html)
DE (1) DE60234831D1 (cg-RX-API-DMAC7.html)
DK (1) DK1404357T3 (cg-RX-API-DMAC7.html)
ES (1) ES2338217T3 (cg-RX-API-DMAC7.html)
GB (1) GB0117057D0 (cg-RX-API-DMAC7.html)
MY (1) MY139203A (cg-RX-API-DMAC7.html)
PT (1) PT1404357E (cg-RX-API-DMAC7.html)
UY (1) UY27378A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003006049A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117057D0 (en) * 2001-07-12 2001-09-05 Ferring Bv Pharmaceutical composition
ME00509B (me) 2002-09-27 2011-10-10 Zentaris Gmbh Oblik za terapijsku primjenu aktivnih peptida sa dugotrajnim oslobođenjem aktivnog sastojka i postupak za njihovo dobijanje
CA2540838C (en) 2003-10-03 2014-12-16 Thorn Bioscience, Llc Process for the synchronization of ovulation for timed breeding without heat detection
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
EP2120859B1 (en) * 2006-12-21 2013-11-20 Stryker Corporation Sustained-release formulations comprising bmp-7 crystals
TWI442932B (zh) 2008-02-11 2014-07-01 Ferring Int Ct Sa 以ＧｎＲＨ拮抗劑治療攝護腺癌的方法
ES2661240T3 (es) 2009-04-23 2018-03-28 Jbs United Animal Health Ii Llc Método y composición para sincronizar el momento de inseminación
JO3550B1 (ar) * 2009-05-01 2020-07-05 Ferring Int Center Sa مركب لمعالجة سرطان البروستاتا
KR101795643B1 (ko) * 2009-05-01 2017-11-09 훼링 비.브이. 전립선암 치료용 조성물
TW201043221A (en) * 2009-05-06 2010-12-16 Ferring Int Ct Sa Kit and method for preparation of a Degarelix solution
US20110039787A1 (en) * 2009-07-06 2011-02-17 Ferring International Center S.A. Compositions, kits and methods for treating benign prostate hyperplasia
EP2447276A1 (en) 2010-10-27 2012-05-02 Ferring B.V. Process for the manufacture of Degarelix and its intermediates
WO2012055903A1 (en) 2010-10-27 2012-05-03 Ferring B.V. Process for the manufacture of degarelix and its intermediates
JO3755B1 (ar) 2011-01-26 2021-01-31 Ferring Bv تركيبات تستوستيرون
WO2013104745A1 (en) * 2012-01-13 2013-07-18 Ferring Bv Pharmaceutical composition
KR102140982B1 (ko) 2012-06-01 2020-08-05 훼링 비.브이. 데가렐릭스의 제조 방법
ITMI20121638A1 (it) 2012-10-02 2014-04-03 Marco Sbracia Utilizzo di degarelix nel trattamento dell'endometriosi e di patologie ad essa correlate
WO2014085674A1 (en) 2012-11-28 2014-06-05 Jbs United Animal Health Ii Llc Method for synchronizing time of insemination in gilts
US10681261B2 (en) * 2012-11-30 2020-06-09 3I Avi, Llc Inspection system
TW201625218A (zh) * 2014-04-18 2016-07-16 Ｊｂｓ聯合動物保健有限責任公司 製造含ｇｎｒｈ凝膠之方法
JP6990717B2 (ja) * 2017-01-30 2022-02-03 アンテヴ リミテッド 少なくとも１種のｇｎｒｈアンタゴニストを含む組成物
WO2019110688A1 (en) 2017-12-05 2019-06-13 Ferring B.V. A composition comprising degarelix for use in the treatment of breast cancer
EP3560555A1 (en) 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US200486A (en) * 1878-02-19 Improvement in apparatus for attaching harness to the shafts
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
ATE144538T1 (de) * 1991-04-25 1996-11-15 Romano Deghenghi Lhrh-antagonisten
SI9300468A (en) * 1992-10-14 1994-06-30 Hoffmann La Roche Injectable composition for the sustained release of biologically active compounds
US5506207A (en) * 1994-03-18 1996-04-09 The Salk Institute For Biological Studies GNRH antagonists XIII
US5595760A (en) * 1994-09-02 1997-01-21 Delab Sustained release of peptides from pharmaceutical compositions
US5860957A (en) * 1997-02-07 1999-01-19 Sarcos, Inc. Multipathway electronically-controlled drug delivery system
US5821230A (en) * 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
US5925730A (en) * 1997-04-11 1999-07-20 Ferring Bv GnRH antagonists
FR2776520B1 (fr) * 1998-03-25 2000-05-05 Sod Conseils Rech Applic Nouvelles compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation
US20020103131A1 (en) * 2001-01-26 2002-08-01 Jacobson Jill D. Prevention of diabetes by administration of GnRH antagonists
GB0117057D0 (en) * 2001-07-12 2001-09-05 Ferring Bv Pharmaceutical composition
AR042815A1 (es) * 2002-12-26 2005-07-06 Alza Corp Dispositivo de suministro de agente activo que tiene miembros compuestos
EP1674082A1 (de) * 2004-12-22 2006-06-28 Zentaris GmbH Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel
EP1891964A1 (en) * 2006-08-08 2008-02-27 AEterna Zentaris GmbH Application of initial doses of LHRH analogues and maintenance doses of LHRH antagonists for the treatment of hormone-dependent cancers and corresponding pharmaceutical kits
TWI442932B (zh) * 2008-02-11 2014-07-01 Ferring Int Ct Sa 以ＧｎＲＨ拮抗劑治療攝護腺癌的方法
ES2589322T3 (es) * 2008-02-11 2016-11-11 Safety Syringes, Inc. Jeringa con protector de seguridad de aguja y clip para evitar la liberación del protector durante un proceso de reconstitución
KR101795643B1 (ko) * 2009-05-01 2017-11-09 훼링 비.브이. 전립선암 치료용 조성물
TW201043221A (en) * 2009-05-06 2010-12-16 Ferring Int Ct Sa Kit and method for preparation of a Degarelix solution
US20110039787A1 (en) * 2009-07-06 2011-02-17 Ferring International Center S.A. Compositions, kits and methods for treating benign prostate hyperplasia
WO2012055903A1 (en) * 2010-10-27 2012-05-03 Ferring B.V. Process for the manufacture of degarelix and its intermediates
EP2447276A1 (en) * 2010-10-27 2012-05-02 Ferring B.V. Process for the manufacture of Degarelix and its intermediates
JO3755B1 (ar) * 2011-01-26 2021-01-31 Ferring Bv تركيبات تستوستيرون
EP2731607B1 (en) * 2011-07-15 2017-10-11 Ferring B.V. Method for timing a colonoscopy wherein a picosulate composition is administered

Similar Documents

Publication Publication Date Title
ES2222633T3 (es) Terapia combinada para la profilaxis y/o el tratamiento de la hiperplasia prostatica benigna.
JP4845166B2 (ja) ゲルを形成する濃度の性腺刺激ホルモン放出ホルモン拮抗物質
ES2298570T3 (es) Composiciones farmaceuticas que comprenden derivados de estetrol para el uso en la terapia del cancer.
JP2719233B2 (ja) 黄体形成ホルモン放出ホルモン拮抗ペプチド
RU2007101304A (ru) Модуляторы рецептора прогестерона, содержащие производные пиррол-оксиндола и применение
MXPA02010066A (es) Estratrienos sustituidos en 8beta-hidrocarbilo para uso como estrogenos selectivos.
SE0100567D0 (sv) Compounds
EA200970348A1 (ru) Новые инъецируемые депо-композиции и способ получения таких композиций
HU211882A9 (en) Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
ES2206622T3 (es) Uso de un analogo de hormona liberadora de gonadotropina.
RU2004102507A (ru) Композиция с регулируемым высвобождением и способ ее получения
EA200601724A1 (ru) Новые композиции для местной доставки
BRPI1011439B1 (pt) composlção de alta penetração, composição farmacêutica, sistemas de aplicação terapêutico transdérmico e uso de referida composição
JP2003206240A5 (cg-RX-API-DMAC7.html)
JP2005516904A5 (cg-RX-API-DMAC7.html)
WO2004017961A3 (en) Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
RU2008119462A (ru) Конденсированное гетероциклическое производное, содержащая его лечебная композиция и ее применение в медицине
EP1877059B8 (en) Micronized tanaproget and compostions containing same
CA2381461A1 (en) Lhrh antagonists having improved solubility properties
EP1782830A1 (en) Preventive and/or remedy for lower urinary tract diseases containing ep4 agonist
JPS60260594A (ja) ＧｎＲＨ拮抗物質
JP2021529165A5 (cg-RX-API-DMAC7.html)
ATE434434T1 (de) Zusammensetzungen mit mikronisiertem tanaproget
CN114903902A (zh) GnRH受体拮抗剂联合雄激素受体拮抗剂在制备治疗前列腺癌药物中的用途
JP2003026601A (ja) 医薬組成物およびその製造法